-
STING activator 2′3′-cGAMP enhanced HSV-1-based oncolytic viral therapy
Sibal, PA; Matsumura, S; Ichinose, T; Bustos-Villalobos, I; Morimoto, D; Eissa, IR; Abdelmoneim, M; Aboalela, MAM; Mukoyama, N; Tanaka, M; Naoe, Y; Kasuya, H
MOLECULAR ONCOLOGY
Vol.
18
(
5
)
page：
1259
-
1277
2024.5
-
The Impact of Metformin on Tumor-Infiltrated Immune Cells: Preclinical and Clinical Studies
Abdelmoneim, M; Aboalela, MA; Naoe, Y; Matsumura, S; Eissa, IR; Bustos-Villalobos, I; Sibal, PA; Takido, Y; Kodera, Y; Kasuya, H
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Vol.
24
(
17
)
2023.9
-
Novel new cell therapy of chimeric antigen receptors into dendritic cells
Naoe, Y; Abdelmoneim, MA; Aboalela, M; Eissa, IR; Matsumura, S; Kasuya, H
CANCER SCIENCE
Vol.
114
page：
997
-
997
2023.2
-
Expression of CAR Targets on Solid Tumors by Armed Oncolytic virus has synergetic effect on CAR-T cell therapy
Aboalela, MA; Abdelmoneim, MA; Naoe, Y; Matsumura, S; Kasuya, H
CANCER SCIENCE
Vol.
114
page：
994
-
994
2023.2
-
Expression of CAR Targets on Solid Tumors by Armed Oncolytic virus has synergetic effect on CAR-T cell therapy
Aboalela, MA; Abdelmoneim, MA; Naoe, Y; Matsumura, S; Kasuya, H
CANCER SCIENCE
Vol.
114
page：
1419
-
1419
2023.2
-
Novel armed oncolytic HSV exhibits strong antitumor effects that lead to complete tumor regression
Abdelmoneim, MA; Naoe, Y; Eissa, IR; Aboalela, MA; Matsumura, S; Tanaka, M; Kasuya, H
CANCER SCIENCE
Vol.
114
page：
1855
-
1855
2023.2
-
Metformin enhances the antitumor activity of oncolytic herpes simplex virus HF10 (canerpaturev) in a pancreatic cell cancer subcutaneous model
Abdelmoneim, M; Eissa, IR; Aboalela, MA; Naoe, Y; Matsumura, S; Sibal, PA; Bustos-Villalobos, I; Tanaka, M; Kodera, Y; Kasuya, H
SCIENTIFIC REPORTS
Vol.
12
(
1
)
page：
21570
2022.12
-
An international medical education perspective on training in child and adolescent psychiatry
Aleksic, B; Kasuya, H
ASIA-PACIFIC PSYCHIATRY
Vol.
14
(
2
)
page：
e12509
2022.6
-
Oncolytic HSV HF10 (canerpaturev, C-REV) promotes accumulation of CD8+PD-1-tumor-infiltrating T cells in a SCC model
Mohamed, AA; Eissa, IR; Mukoyama, N; Abdelmoneim, M; Naoe, Y; Matsumura, S; Bustosvillalobos, I; Ichinose, T; Miyajima, N; Morimoto, D; Tanaka, M; Fujimoto, Y; Sone, M; Kodera, Y; Kasuya, H
CANCER SCIENCE
Vol.
113
page：
526
-
526
2022.2
-
S-1 facilitates canerpaturev (C-REV)-induced antitumor efficacy in a triple-negative breast cancer model
Miyajima, N; Eissa, IR; Abdelmoneim, M; Naoe, Y; Ichinose, T; Matsumura, S; Bustos-Villalobos, I; Mukoyama, N; Morimoto, D; Shibata, M; Takeuchi, D; Tsunoda, N; Kikumori, T; Tanaka, M; Kodera, Y; Kasuya, H
NAGOYA JOURNAL OF MEDICAL SCIENCE
Vol.
83
(
4
)
page：
683
-
696
2021.11
-
Oncolytic herpes simplex virus HF10 (canerpaturev) promotes accumulation of CD8<SUP>+</SUP>PD-1<SUP>-</SUP> tumor-infiltrating T cells in PD-L1-enriched tumor microenvironment
Eissa, IR; Mukoyama, N; Abdelmoneim, M; Naoe, Y; Matsumura, S; Bustos-Villalobos, I; Ichinose, T; Miyajima, N; Morimoto, D; Tanaka, M; Fujimoto, Y; Sone, M; Kodera, Y; Kasuya, H
INTERNATIONAL JOURNAL OF CANCER
Vol.
149
(
1
)
page：
214
-
227
2021.7
-
C-REV Retains High Infectivity Regardless of the Expression Levels of cGAS and STING in Cultured Pancreatic Cancer Cells
Morimoto, D; Matsumura, S; Bustos-Villalobos, I; Sibal, PA; Ichinose, T; Naoe, Y; Eissa, IR; Abdelmoneim, M; Mukoyama, N; Miyajima, N; Tanaka, M; Kodera, Y; Kasuya, H
CELLS
Vol.
10
(
6
)
2021.6
-
Problem-Based Learning in Child and Adolescent Psychiatry: A Perspective from Japan
Iwatsuki, J; Kondo, T; Takahashi, N; Takami, H; Nishigori, H; Bustos-Villalobos, I; Aleksic, B; Kasuya, H; Ban, NO; Yagi, T; Skokauskas, N
ADVANCES IN MEDICAL EDUCATION AND PRACTICE
Vol.
12
page：
1329
-
1335
2021
-
Continuing medical education during pandemic waves of COVID-19: Consensus from medical faculties in Asia, Australia and Europe.
Wong C, van den Broek W, Doody G, Fischer M, Leech M, De Ponti F, Gerbes A, Nishigori H, Lee YM, Frens M, Kasuya H, Bazzoli F, Hickel R, Lee HS, van Leeuwen JPTM, Mitchell C, Kadomatsu K, Atherton J, Chan F
MedEdPublish (2016)
Vol.
10
page：
64
2021
-
S-1 Facilitates C-REV Induced Anti-Tumor Efficacy in Triple Negative Breast Cancer Model
Kasuya, H; Naoe, Y; Matsumura, S; Bustos, I; Eissa, I; Mohamed, A; Tanaka, M
MOLECULAR THERAPY
Vol.
28
(
4
)
page：
163
-
163
2020.4
-
Phase I study of the oncolytic viral immunotherapy agent canerpaturev (C-REV) with S-1 in patients with stage IV pancreatic cancer
International journal
Hijioka, S; Ueno, M; Ioka, T; Hirooka, Y; Ohno, E; Okusaka, T; Maruki, Y; Kobayashi, S; Ashida, R; Yashika, J; Furuse, J; Ikeda, M; Kasuya, H; Tanaka, M; Hashimoto, Y
ANNALS OF ONCOLOGY
Vol.
30
2019.10
-
Results from phase I study of the oncolytic viral immunotherapy agent Canerpaturev (C-REV) in combination with gemcitabine plus nab-paclitaxel as first-line treatment of unresectable pancreatic cancer
International journal
Hashimoto, Y; Hijioka, S; Hirooka, Y; Ohno, E; Ioka, T; Kobayashi, S; Okusaka, T; Maruki, Y; Yashika, J; Ashida, R; Furuse, J; Ikeda, M; Kasuya, H; Tanaka, M; Ueno, M
ANNALS OF ONCOLOGY
Vol.
30
page：
269
-
+
2019.10
-
Combination of Cetuximab and Oncolytic Virus Canerpaturev Synergistically Inhibits Human Colorectal Cancer Growth
Reviewed
International journal
Wu, ZW; Ichinose, T; Naoe, Y; Matsumura, S; Villalobos, IB; Eissa, IR; Yamada, S; Miyajima, N; Morimoto, D; Mukoyama, N; Nishikawa, Y; Koide, Y; Kodera, Y; Tanaka, M; Kasuya, H
MOLECULAR THERAPY-ONCOLYTICS
Vol.
13
page：
107
-
115
2019.6
-
Joint Degree Program for Graduate Students at the Nagoya University Graduate School of Medicine
Reviewed
Kasuya, H; Aleksic, B; Sumigama, S; Bustos, I; Hasegawa, H; Kasai, MP; Kobayashi, M; Samizo, Y
NAGOYA JOURNAL OF MEDICAL SCIENCE
Vol.
81
(
2
)
page：
183
-
192
2019.5
-
STING is dispensable for low susceptibility for HF10 in pancreatic cell lines
Matsumura, S; Morimoto, D; Noe, Y; Ichinose, T; Tanaka, M; Kodera, Y; Kasuya, H
CANCER SCIENCE
Vol.
109
page：
1328
-
1328
2018.12
-
The Current Status and Future Prospects of Oncolytic Viruses in Clinical Trials against Melanoma, Glioma, Pancreatic, and Breast Cancers.
Eissa IR, Bustos-Villalobos I, Ichinose T, Matsumura S, Naoe Y, Miyajima N, Morimoto D, Mukoyama N, Zhiwen W, Tanaka M, Hasegawa H, Sumigama S, Aleksic B, Kodera Y, Kasuya H
Cancers
Vol.
10
(
10
)
2018.10
-
A Phase I clinical trial of EUS-guided intratumoral injection of the oncolytic virus, HF10 for unresectable locally advanced pancreatic cancer
International journal
Hirooka Yoshiki, Kasuya Hideki, Ishikawa Takuya, Kawashima Hiroki, Ohno Eizaburo, Villalobos Itzel B., Naoe Yoshinori, Ichinose Toru, Koyama Nobuto, Tanaka Maki, Kodera Yasuhiro, Goto Hidemi
BMC CANCER
Vol.
18
(
1
)
page：
596
2018.5
-
Curative effect of HF10 on liver and peritoneal metastasis mediated by host antitumor immunity
Reviewed
Yoshihiro Hotta, Hideki Kasuya, Itzel Bustos, Yoshinori Naoe, Toru Ichinose, Maki Tanaka, Yasuhiro Kodera
Oncolytic Virotherapy
Vol.
6
page：
31—38
2017.3
-
Curative effect of HF10 on liver and peritoneal metastasis mediated by host antitumor immunity.
Hotta Y, Kasuya H, Bustos I, Naoe Y, Ichinose T, Tanaka M, Kodera Y
Oncolytic virotherapy
Vol.
6
page：
31
-
38
2017
-
Genomic Signature of the Natural Oncolytic Herpes Simplex Virus HF10 and Its Therapeutic Role in Preclinical and Clinical Trials
Reviewed
Ibrahim Ragab Eissa, Yoshinori Naoe, Itzel Bustos-Villalobos, Toru Ichinose, Maki Tanaka, Wu Zhiwen, Nobuaki Mukoyama, Taishi Morimoto, Noriyuki Miyajima, Hasegawa Hitoki, Seiji Sumigama, Branko Aleksic, Yasuhiro Kodera and Hideki Kasuya
Front. Oncol.
Vol.
7
page：
149
2017
-
Combination therapy of oncolytic herpes simplex virus HF10 and bevacizumab against experimental model of human breast carcinoma xenograft
Reviewed
Gewen Tan, Hideki Kasuya, Tevfik Tolga Sahin, Kazuo Yamamura, Zhiwen Wu, Yusuke Koide, Yoshihiro Hotta, Toshio Shikano, Suguru Yamada, Akiyuki Kanzaki, Tsutomu Fujii, Hiroyuki Sugimoto, Shuji Nomoto, Yoko Nishikawa, Maki Tanaka, Naoko Tsurumaru, Toshie Kuwahara, Saori Fukuda, Toru Ichinose, Toyone Kikumori, Shin Takeda, Akimasa Nakao and Yasuhiro Korea
International Journal of Cancer
Vol.
136
(
7
)
page：
1718–1730
2015.4
-
Phase I Dose-escalation Clinical Trial of HF10 Oncolytic Herpes Virus in 17 Japanese Patients with Advanced Cancer
Reviewed
Hideki Kasuya, Yasuhiro Kodera, Akimasa Nakao, Kazuo Yamamura, Tan Gewen, Wu Zhiwen, Yoshihiro Hotta, Suguru Yamada, Tsutomu Fujii, Saori Fukuda, Naoko Tsurumaru, Toshie Kuwahara, Toyone Kikumori, Yusuke Koide, Yasushi Fujimoto, Tsutomu Nakashima, Yoshiki Hirooka, Hiroshi Shiku, Maki Tanaka, Kazuto Takesako, Touru Kondo, Branko Aleksic, Hiroki Kawashima, Hidemi Goto, Yukihiro Nishiyama
Hepato-Gastroenterology
Vol.
61
(
131
)
page：
599-605
2014.5
-
Combination treatment of human pancreatic cancer xenograft models with the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib and oncolytic herpes simplex virus HF10.
Reviewed
Yamamura K, Kasuya H, Sahin TT, Tan G, Hotta Y, Tsurumaru N, Fukuda S, Kanda M, Kobayashi D, Tanaka C, Yamada S, Nakayama G, Fujii T, Sugimoto H, Koike M, Nomoto S, Fujiwara M, Tanaka M, Kodera Y.
Ann Surg Oncol
Vol.
21
(
2
)
page：
691-8
2014.2
-
Impact of novel oncolytic virus HF10 on cellular components of the tumor microenviroment in patients with recurrent breast cancer
Tevfik Tolga Sahin, Hideki Kasuya, Naohiro Nomura, Toshio Shikano, Tan Gewen, Akiyuki Kanzaki, Tsutomu Fujii, Takashi Sugae, Tsuneo Imai, Shuji Nomoto, Shin Takeda, Hiroyuki Sugimoto, Toyone Kikumori, Yasuhiro Kodera, Yukihiro Nishiyama, Akimasa Nakao
Cancer Gene Therapy
Vol.
19
(
4
)
page：
229-237
2012.4
-
Antitumor efficacy of oncolytic herpes simplex virus adsorbed onto antigen-specific lymphocytes
Akiyuki Kanzaki, Hideki Kasuya, Kazuo Yamamura, Tevfik Tolga Sahin, Naohiro Nomura, Toshio Shikano, Takashi Shirota, Tan Gewen, Saori Fukuda, Makoto Misawa, Yoko Nishikawa, Suguru Yamada, Tsutomu Fujii, Hiroyuki Sugimoto, Shuji Nomoto, Shin Takeda Yasuhiro Kodera, Akimasa Nakao
Cancer Gene Therapy
Vol.
19
(
4
)
page：
292-298
2012.4
-
Prognostic implications of lymph node metastases in carcinoma of the body and tail of the pancreas.
Sahin TT, Fujii T, Kanda M, Nagai S, Kodera Y, Kanzaki A, Yamamura K, Sugimoto H, Kasuya H, Nomoto S, Takeda S, Morita S, Nakao A.
Pancreas
page：
40(7):1029-33
2011.10
-
Oncolytic Herpes Virus Induces Effective Anti-Cancer Immunity against Murine Colon Cancer.
Shirota T, Kasuya H, Kodera Y, Nishikawa Y, Shikano T, Sahin TT, Gewen T, Yamamura K, Kanzaki A, Yamada S, Fujii T, Sugimoto H, Nomoto S, Takeda S, Nakao A.
Hepatogastroenterology
page：
58(110-111)
2011.7
-
特集：膵疾患画像診断における最近の進歩 膵癌に対する術中超音波検査の最近の進歩
杉本博行,竹田 伸,野本周嗣,粕谷英樹,藤井 努,中尾昭公
膵臓
Vol.
26
(
1
)
page：
66-71
2011.2
-
A phase I dose-escalation clinical trial of intraoperative direct intratumoral injection of HF10 oncolytic virus in non-resectable patients with advanced pancreatic cancer.
Nakao A, Kasuya H, Sahin TT, Nomura N, Kanzaki A, Misawa M, Shirota T, Yamada S, Fujii T, Sugimoto H, Shikano T, Nomoto S, Takeda S, Kodera Y, Nishiyama Y.
Cancer Gene Ther.
page：
18(3):167-75
2010.11
-
Medial prefrontal cortex-dorsal anterior cingulate cortex connectivity during behavior selection without an objective correct answer.
Nakao T, Osumi T, Ohira H, Kasuya Y, Shinoda J, Yamada J, Northoff G.
Neurosci Lett.
page：
4;482(3):220-4
2010.10
-
Clinical Trial of HF10 Oncolytic Virus Therapy for Advanced Pancreatic Cancer, Cancer Gene Ther.
Reviewed
19. Akimasa Nakao, Hideki Kasuya, Tevfik Tolga Sahin, Naohiro Nomura, Akiyuki Kanzaki, Makoto Misawa, Takashi Shirota, Suguru Yamada, Tsutomu Fujii, Hiroyuki Sugimoto, Toshio Shikano, Shuji Nomoto, Shin Takeda, Yasuhiro Kodera, Yukihiro Nishiyama
Cancer Gene Ther.
page：
2010, July
2010.7
-
High Therapeutic Potential for Systemic Delivery of a Liposome-conjugated Herpes Simplex Virus.
Reviewed
20. Toshio Shikano, Hideki Kasuya, Tevfik Tolga Sahin, Naohiro Nomura, Akiyuki Kanzaki, Makoto Misawa, Yoko Nishikawa, Takashi Shirota, Suguru Yamada, Tsutomu Fujii, Hiroyuki Sugimoto, Naohito Kanazumi, Shuji Nomoto, Shin Takeda and Akimasa Nakao.
CCDT
page：
2010 [June Accepted]
2010.6
-
腫瘍溶解性ウィルス、HF10を使用したトランスレーショナルリサーチ
Reviewed
17. 粕谷英樹、竹田 伸、今井常夫、野本周嗣、野村尚弘、杉本博行、三澤 真、山田 豪、神崎章之、藤井 努、Tevfik Tolga Sahin 、西山幸廣、中尾昭公
外科遺伝子治療フロンティア
page：
2010 1月
2010.1
-
膵癌の腫瘍溶解性ウイルス療法
Reviewed
18. 粕谷英樹、竹田 伸、今井常夫、野本周嗣、野村尚弘、杉本博行、三澤 真、山田 豪、神崎章之、藤井 努、Tevfik Tolga Sahin 、西山幸廣、中尾昭公
膵臓
page：
2010 1月
2010.1
-
Pancreatic head resection with segmental duodenectomy for pancreatic neoplasms.
Reviewed
16. Nakao A, Takeda S, Nomoto S, Kanazumi N, Kasuya H, Sugimoto H, Fujii T, Yamada S.
J Hepatobiliary Pancreat Surg.
page：
2009 Nov 3. [Epub ahead of print]
2009.11
-
Pancreatic cancer with distant metastases: a contraindication for radical surgery?
Reviewed
15. Yamada S, Fujii T, Sugimoto H, Kanazumi N, Kasuya H, Nomoto S, Takeda S, Kodera Y, Nakao A
Hepatogastroenterology
page：
56(91-92):881-5
2009.5
-
Nonfunctioning neuroendocrine pancreatic tumors: our experience and management.
Reviewed
13. Nomura N, Fujii T, Kanazumi N, Takeda S, Nomoto S, Kasuya H, Sugimoto H, Yamada S, Nakao A.
Hepatobiliary Pancreat Surg.
page：
2009 Apr 14
2009.4
-
The tumor suppressor NPRL2 in hepatocellular carcinoma plays an important role in progression and can be served as an independent prognostic factor.
Reviewed
14. Otani S, Takeda S, Yamada S, Sakakima Y, Sugimoto H, Nomoto S, Kasuya H, Kanazumi N, Nagasaka T, Nakao A.
J Surg Oncol.
page：
2009 Mar 9
2009.3
-
Considerations for intravascular administration of oncolytic herpes virus for the treatment of multiple liver metastases.
Reviewed
12. Nomura N, Kasuya H, Watanabe I, Shikano T, Shirota T, Misawa M, Sugimoto H, Kanazumi N, Nomoto S, Takeda S, Nakao A.
Cancer Chemother Pharmacol.
page：
63(2): 321-30
2009.1
-
Effects of tumor selective replication-competent herpes viruses in combination with gemcitabine on pancreatic cancer.
Reviewed
10. Watanabe I, Kasuya H, Nomura N, Kanazumi N,Takeda S, Nomoto S, Shikano T, Shirota T, Sugimoto H, Nakao A.
Cancer Chemoth Pharm
page：
61(5):875-82
2008.4
-
Hypermethylation of multiple genes as clonal markers in multicentric hepatocellular carcinoma.
Reviewed
Nomoto S, Kinoshita T, Kato K, Otani S, Kasuya H, Takeda S, Kanazumi N, Sugimoto H, Nakao A.
Br J Cancer.
Vol.
97
(
9
)
page：
1260-1265
2007.11
-
Hypermethylation of multiple genes as clonal markers in multicentric hepatocellular carcinoma.
Reviewed
11. Nomoto S, Kinoshita T, Kato K, Otani S, Kasuya H, Takeda S, Kanazumi N, Sugimoto H, Nakao A.
Br J Cancer.
page：
5;97(9):1260-5.
2007.11
-
Clinical implications of peritoneal cytology in potentially resectable pancreatic cancer: positive peritoneal cytology may not confer an adverse prognosis.
7. Yamada S, Takeda S, Fujii T, Nomoto S, Kanazumi N, Sugimoto H, Kasuya H, Kodera Y, Nagasaka T, Morita S, Nakao A.
Ann Surg
page：
246(2):254-8
2007.8
-
*Suitability of a US3-inactivated HSV mutant (L1BR1) as an oncolytic virus for pancreatic cancer therapy
Reviewed
Kasuya H, Nishiyama Y, Nomoto S, Goshima F, Takeda S, Watanabe I, Nomura N, Shikano T, Fujii T, Kanazumi N, Nakao A.
Cancer Gene Ther
Vol.
14
(
6
)
page：
533-542
2007.6
-
Enhanced efficacy of herpes simplex virus mutant HF10 combined with paclitaxel in peritoneal cancer dissemination models.
Reviewed
Shimoyama S, Goshima F, Teshigahara O, Kasuya H, Kodera Y, Nakao A, Nishiyama Y.
Hepatogastroenterology
Vol.
54
(
76
)
page：
1038-1042
2007.6
-
*Oncolytic virus therapy--foreword
Invited
Kasuya H, Takeda S, Shimoyama S, Shikano T, Nomura N, Kanazumi N, Nomoto S, Sugimoto H, Nakao A.
Curr Cancer Drug Targets
Vol.
7
(
2
)
page：
123-125
2007.3
-
Clinical experiment of mutant herpes simplex virus HF10 therapy for cancer.
Reviewed
Nakao A, Takeda S, Shimoyama S, Kasuya H, Kimata H, Teshigahara O, Sawaki M, Kikumori T, Kodera Y, Nagasaka T, Goshima F, Nishiyama Y, Imai T.
Curr Cancer Drug Targets.
Vol.
74
(
29
)
page：
169-174
2007.3
-
Clinical application of replication competent mutant HSV in cancer therapy
Invited
Kasuya H, Nakao A.
Nippon Rinsho
Vol.
64
(
3
)
page：
335-339
2006.3
-
*The potential of oncolytic virus therapy for pancreatic cancer
Reviewed
Kasuya H, Takeda S, Nomoto S, Nakao A.
Cancer Gene Ther
Vol.
12
(
9
)
page：
725-736
2005.9
-
*Mouse models of subcutaneous spleen reservoir for multiple portal venous injections to treat liver malignancies
Reviewed
Kasuya H, Kuruppu DK, Donahue JM, Choi EW, Kawasaki H, Tanabe KK.
Cancer Res
Vol.
65
(
9
)
page：
3823-3827
2005.5
-
Oncolysis by viral replication and inhibition of angiogenesis by a replication-conditional herpes simplex virus that expresses mouse endostatin.
Reviewed
Mullen JT, Donahue JM, Chandrasekhar S, Yoon SS, Liu W, Ellis LM, Nakamura H, Kasuya H, Pawlik TM, Tanabe KK.
Cancer.
Vol.
101
(
4
)
page：
869-877
2004.8
-
*Selectivity of an oncolytic herpes simplex virus for cells expressing the DF3/MUC1 antigen
Reviewed
Kasuya H, Pawlik TM, Mullen JT, Donahue JM, Nakamura H, Chandrasekhar S, Kawasaki H, Choi E, Tanabe KK.
Cancer Res
Vol.
64
(
7
)
page：
2561-2567
2004.4
-
Regulation of herpes simplex virus 1 replication using tumor-associated promoters.
Reviewed
Mullen JT, Kasuya H, Yoon SS, Carroll NM, Pawlik TM, Chandrasekhar S, Nakamura H, Donahue JM, Tanabe KK.
Ann Surg.
Vol.
236
(
4
)
page：
502-512
2002.10
-
Prodrug bioactivation and oncolysis of diffuse liver metastases by a herpes simplex virus 1 mutant that expresses the CYP2B1 transgene.
Reviewed
Pawlik TM, Nakamura H, Mullen JT, Kasuya H, Yoon SS, Chandrasekhar S, Chiocca EA, Tanabe KK.
Cancer.
Vol.
95
(
5
)
page：
1171-1181
2002.9
-
The potential of gene therapy in the treatment of pancreatic cancer
Reviewed
Kasuya H, Nomoto S, Nakao A.
Drugs Today (Barc)
Vol.
38
(
7
)
page：
457-464
2002.7
-
Regulation of herpes simplex virus gamma(1)34.5 expression and oncolysis of diffuse liver metastases by Myb34.5.
Reviewed
Nakamura H, Kasuya H, Mullen JT, Yoon SS, Pawlik TM, Chandrasekhar S, Donahue JM, Chiocca EA, Chung RY, Tanabe KK.
J Clin Invest.
Vol.
109
(
7
)
page：
871-882.
2002.4
-
Gene therapy for pancreatic cancer
Reviewed
Kasuya H, Nomoto S, Kimata H, Harada A, Takeda S, Hayashi S, Nakao A.
Hepatogastroenterology
Vol.
48
(
40
)
page：
957-961
2001.7
-
Clinical implications of peritoneal cytology in potentially resectable pancreatic cancer: positive peritoneal cytology may not confer an adverse prognosis.
Reviewed
Yamada S, Takeda S, Fujii T, Nomoto S, Kanazumi N, Sugimoto H, Kasuya H, Kodera Y, Nagasaka T, Morita S, Nakao A.
Ann Surg
Vol.
246
(
29
)
page：
254-258
2000.8
-
Combined effects of adeno-associated virus vector and a herpes simplex virus mutant as neoplastic therapy.
Reviewed
Kasuya H, Mizuno M, Yoshida J, Nishiyama Y, Nomoto S, Nakao A.
J Surg Oncol.
Vol.
74
(
3
)
page：
214-218.
2000.7
-
Preserving gastroduodenal artery, pancreas head resection with second potion of duodenum intestine against mucin producing pancreastic tumor.
Reviewed
Nakao A, Kaneko T, Takeda S, Inoue S, Nomoto S, Kasuya H, Koshikawa H
The Operation
Vol.
54
page：
21-26
2000
-
Three clinical records of respectable metastatic pancreastic tumor.
Reviewed
Ishigure H, Kawase Y, Kanazumi N, Oshima K, Kotake K, Kasuya H, Sawada K, Nonami T, Harada A, Nakao A.
Japan Gastro-Intestinall Surgery Association (Japan)
Vol.
33
page：
1686
2000
-
Resection with preserving function of pancreass.
Reviewed
Nakao A, Kaneko T, Takeda S, Inoue S, Nomoto S, Kasuya H, Koshikawa H.
Surgery (Japan)
Vol.
62
page：
416-421
2000
-
Intraperitoneal delivery of hrR3 and ganciclovir prolongs survival in mice with disseminated pancreatic cancer
Reviewed
Kasuya H, Nishiyama Y, Nomoto S, Hosono J, Takeda S, Nakao A.
J Surg Oncol
Vol.
72
(
3
)
page：
136-141
1999.11
-
Peritoneal washings cytology combined with immunocytochemical staining in pancreatic cancer.
Reviewed
Nakao A, Oshima K, Takeda S, Kaneko T, Kanazumi N, Inoue S, Nomoto S, Kawase Y, Kasuya H.
Hepatogastroenterology.
Vol.
46
(
29
)
page：
2974-2977
1999.9
-
Virall therapy using a replication-competennt HSV mutant (hrR3) for disseminated pancreastic cancer in mice.
Kasuya H, Nakao A, Kimata H, Nomoto S.
Journal of the Japan Pancreas Society
Vol.
14
(
3
)
1999
-
Preserving gastroduodenal artery, pancreas head resection with second potion of duodenum intestine.
Reviewed
Nakao A, Oshima K, Kaneko T, Takeda S, Kanazumi N, Kasuya H,
The Operation
Vol.
1
page：
33-38
1999
-
Postoperative delayed emptying in pylorus-preserving pancreatoduodenectomy using pancreaticogastrostomy: comparison of the reconstruction position.
Reviewed
Kasuaya H, Nakao A, Nomoto S, Hosono J, Takeda S, Kaneko T, Takagi H.
Hepatogastroenterology.
Vol.
44
(
15
)
page：
856-860
1997.5
